Stay updated with breaking news from Nyse Ocx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equities researchers at StockNews.com assumed coverage on shares of OncoCyte (NYSE:OCX – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the stock. OncoCyte Stock Performance OncoCyte Company Profile (Get Free Report) OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the […]
StockNews.com began coverage on shares of OncoCyte (NYSE:OCX – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the stock. OncoCyte Stock Performance OCX opened at $4.28 on Friday. OncoCyte has a 52-week low of $3.80 and a 52-week high of $22.00. OncoCyte Company Profile (Get […]
Research analysts at StockNews.com began coverage on shares of OncoCyte (NYSE:OCX – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “sell” rating on the stock. OncoCyte Stock Performance OncoCyte Company Profile (Get Free Report) OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary […]
StockNews.com started coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research report report published on Tuesday. The brokerage issued a sell rating on the stock. OncoCyte Stock Performance NYSE OCX opened at $0.21 on Tuesday. OncoCyte has a 1-year low of $0.20 and a 1-year high of $1.10. OncoCyte (NYSE:OCX – Get […]
Equities research analysts at StockNews.com began coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research report issued on Sunday. The firm set a “sell” rating on the stock. OncoCyte Price Performance About OncoCyte (Get Rating) OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of […]